PMDA drug package insert
ヒーロン眼粘弾剤1%シリンジ0.4mL
PMDA Prescription drug · エイエムオー・ジャパン株式会社 · package insert Jun 21, 2023
Key facts
| Brand names | ヒーロン眼粘弾剤1%シリンジ0.4mL, ヒーロン眼粘弾剤1%シリンジ0.6mL, ヒーロン眼粘弾剤1%シリンジ0.85mL |
|---|---|
| Nonproprietary names | 精製ヒアルロン酸ナトリウム |
| Companies | 製造販売元／エイエムオー・ジャパン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 眼科手術補助剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319720Q1164, 1319720Q7227, 1319720Q8215 |
| Approval numbers | 23000AMX00202000, 23000AMX00203000, 23000AMX00204000 |
| Package insert edition | 第1版 |
| Package insert date | Jun 21, 2023 |
| PMDA document key | 630215_1319720Q1164_1 |
| PMDA company code | 630215 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: